Abbott Laboratories (ABT)
Current ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 22,670,000 | 22,664,000 | 23,505,000 | 24,377,000 | 25,224,000 | 24,845,000 | 24,956,000 | 23,429,000 | 24,239,000 | 23,492,000 | 22,627,000 | 21,817,000 | 20,441,000 | 17,390,000 | 17,221,000 | 15,498,000 | 15,667,000 | 16,119,000 | 15,195,000 | 14,409,000 |
Total current liabilities | US$ in thousands | 13,841,000 | 13,042,000 | 14,350,000 | 14,530,000 | 15,489,000 | 13,365,000 | 12,392,000 | 12,647,000 | 13,105,000 | 12,867,000 | 12,614,000 | 12,462,000 | 11,907,000 | 10,257,000 | 10,959,000 | 10,808,000 | 10,863,000 | 10,491,000 | 9,062,000 | 9,113,000 |
Current ratio | 1.64 | 1.74 | 1.64 | 1.68 | 1.63 | 1.86 | 2.01 | 1.85 | 1.85 | 1.83 | 1.79 | 1.75 | 1.72 | 1.70 | 1.57 | 1.43 | 1.44 | 1.54 | 1.68 | 1.58 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $22,670,000K ÷ $13,841,000K
= 1.64
The current ratio for Abbott Laboratories has shown some fluctuation over the past eight quarters. As of Q4 2023, the current ratio stands at 1.64, which indicates that the company has $1.64 in current assets to cover each dollar of current liabilities. This ratio has decreased from the previous quarter, Q3 2023, where it was 1.74.
Looking further back, the current ratio has displayed a general downward trend since Q2 2022, where it peaked at 2.01. This decline may suggest that the company's liquidity position has weakened over time, as it now has a lower ability to meet its short-term obligations with its current assets.
Although the current ratio has declined, it is essential to note that a current ratio above 1.0 still indicates that Abbott Laboratories has more current assets than current liabilities. However, the decreasing trend warrants further analysis to understand the underlying reasons and potential implications for the company's financial health and operational efficiency.
Peer comparison
Dec 31, 2023